Compare Estee Lauder Companies Inc (EL) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Estee Lauder Companies Inc vs Teladoc Health Inc — how do they compare? Estee Lauder Companies Inc trades at $82.55 (market cap $29.78B), while Teladoc Health Inc trades at $9.68 (market cap $1.75B). The key difference: Estee Lauder Companies Inc is far larger — about 17× Teladoc Health Inc's market cap, and Estee Lauder Companies Inc pays a 1.7% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.
| EL | TDOC | |
|---|---|---|
Market Cap | $29.78B | $1.75B |
Sector | Consumer Staples | Health |
52-Week High | $119.61 | $9.72 |
52-Week Low | $67.23 | $4.47 |
Enterprise Value | $35.95B | $2.04B |
Dividend Yield | 1.7% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Estée Lauder (EL) trades at $80.86, down 0.36% on the day, with a bearish technical signal and recent earnings beats. The stock shows a high P/E of 147.8 and negative net income margin of -1.67%, though revenue remains substantial at $14.33 billion for 2025. Recent news highlights innovation in beauty trends, but cash flow trends show net outflows over recent years.
Outlook is mixed: analyst consensus targets $90.60 with 44% buy ratings, but high valuation and profitability challenges pose risks. Recovery depends on margin improvement and sustained revenue growth amid competitive pressures.
TDOC trades at $9.27, down 3.94% on the day, with a bullish technical signal from moving averages. The company reported revenue of $2.53B in 2025 but posted a net loss of $200.32M. Recent news highlights the Walmart partnership expansion and upcoming Q2 2026 earnings. Analyst consensus is mixed with 35.71% buy ratings but a price target below current levels at $8.75.
The outlook remains cautious due to persistent losses despite revenue stability. Investment opportunity exists if cost controls and partnerships drive profitability. Key risks include competitive pressures, weak BetterHelp segment, and negative cash flow trends. The stock faces headwinds until sustainable earnings improvement is demonstrated.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Estee Lauder Companies Inc
Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Read more on EL →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
